BCG PRODUCTS

In Khazaen Economic City in Oman, which is located in Barka (about 70 km from Muscat), We are going to construct a pharmaceutical facility to manufacture BCG products, the most effective immunotherapeutic form of Intravesical Therapy (IVT), which is referred to as a "Sterile Injectable Biological Product."

This extraordinary project in terms of quality and dimension is completely in accordance with the fundamental principles of the World Health Organization (WHO) and Good Manufacturing Practice (GMP) guidelines. We hope it can cover the huge actual shortage of Intravesical BCG against several forms of Bladder Cancer. We consider producing two distinct doses of Intravesical BCG as follows:

No.

Product Name

Useful

1

Lyophilized Intravesical BCG
(81 mg), Single dose / vial

as the primary treatment option for Superficial (non-muscle invasive) Bladder Cancer

2

Lyophilized Intravesical BCG
(120 mg), Single dose / vial

How BCG Therapy Is Performed
Staging of Bladder Tumors:
From Superficial to Metastatic Situation